Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Ponting

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Regulatory Toxicology and Pharmacology : RTP|April 16, 2021
Use of less-than-lifetime (LTL) durational limits for nitrosamines: Case study of N-Nitrosodiethylamine (NDEA)Joel P Bercu, Melisa Masuda-Herrera, George Johnson, et al.
Journal of Pharmaceutical Sciences|November 19, 2022
The Landscape of Potential Small and Drug Substance Related Nitrosamines in PharmaceuticalsJoerg Schlingemann, Michael J Burns, David J Ponting, et al.
Mutagenesis|July 9, 2026
Industrial Genotoxicology Group: 38th Annual Meeting ReportGrace Kocks, Fahima Begum, Peter Ceuppens, et al.
Regulatory Toxicology and Pharmacology : RTP|July 11, 2025
Evaluating the lifetime cumulative dose as a basis for carcinogenic potency of nitrosamines - a key tenet underpinning less-than-lifetime approaches for establishing acceptable intake limitsSusan P Felter, Ashley M Mudd, David J Ponting, et al.
Regulatory Toxicology and Pharmacology : RTP|June 6, 2022
Updating the Dermal Sensitisation Thresholds using an expanded dataset and an in silico expert systemMartyn L Chilton, Anne Marie Api, Robert S Foster, et al.
Chemical Research in Toxicology|February 5, 2024
Mechanisms of Nitrosamine Mutagenicity and Their Relationship to Rodent Carcinogenic PotencyDavid J Snodin, Alejandra Trejo-Martin, David J Ponting, et al.
Regulatory Toxicology and Pharmacology : RTP|May 31, 2023
Acceptable intakes (AIs) for 11 small molecule N-nitrosamines (NAs)Joel P Bercu, Melisa Masuda-Herrera, Alejandra Trejo-Martin, et al.
Regulatory Toxicology and Pharmacology : RTP|February 1, 2026
Ames Concordance with the In Vivo Transgenic Rodent (TGR) Gene Mutation Assay for NDSRIs and Relative In Vivo TGR Potency with Nitrosamines with Robust Dose-Response Carcinogenicity DataRobert Jolly, Alejandra Trejo-Martin, Joel P Bercu, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Regulatory Toxicology and Pharmacology : RTP|April 16, 2021
Use of less-than-lifetime (LTL) durational limits for nitrosamines: Case study of N-Nitrosodiethylamine (NDEA)Joel P Bercu, Melisa Masuda-Herrera, George Johnson, et al.
Journal of Pharmaceutical Sciences|November 19, 2022
The Landscape of Potential Small and Drug Substance Related Nitrosamines in PharmaceuticalsJoerg Schlingemann, Michael J Burns, David J Ponting, et al.
Mutagenesis|July 9, 2026
Industrial Genotoxicology Group: 38th Annual Meeting ReportGrace Kocks, Fahima Begum, Peter Ceuppens, et al.
Regulatory Toxicology and Pharmacology : RTP|July 11, 2025
Evaluating the lifetime cumulative dose as a basis for carcinogenic potency of nitrosamines - a key tenet underpinning less-than-lifetime approaches for establishing acceptable intake limitsSusan P Felter, Ashley M Mudd, David J Ponting, et al.
Regulatory Toxicology and Pharmacology : RTP|June 6, 2022
Updating the Dermal Sensitisation Thresholds using an expanded dataset and an in silico expert systemMartyn L Chilton, Anne Marie Api, Robert S Foster, et al.
Chemical Research in Toxicology|February 5, 2024
Mechanisms of Nitrosamine Mutagenicity and Their Relationship to Rodent Carcinogenic PotencyDavid J Snodin, Alejandra Trejo-Martin, David J Ponting, et al.
Regulatory Toxicology and Pharmacology : RTP|May 31, 2023
Acceptable intakes (AIs) for 11 small molecule N-nitrosamines (NAs)Joel P Bercu, Melisa Masuda-Herrera, Alejandra Trejo-Martin, et al.
Regulatory Toxicology and Pharmacology : RTP|February 1, 2026
Ames Concordance with the In Vivo Transgenic Rodent (TGR) Gene Mutation Assay for NDSRIs and Relative In Vivo TGR Potency with Nitrosamines with Robust Dose-Response Carcinogenicity DataRobert Jolly, Alejandra Trejo-Martin, Joel P Bercu, et al.
Pageof 4